APAC OTC Gastrointestinal Drugs Market Analysis

$3,000.00$7,500.00

  • Type: Common Disease Area
  • Published : January 2022
  • Region: APAC
  • Country: Other
  • Report ID : 5036

  • Format: PPT, PDF

APAC OTC Gastrointestinal Drugs Market Analysis: Segmented by Drug Class, Route of Administration, Application, Distribution Channel- Growth, Market Size, Future Prospects & Competitive Analysis, 2020 – 2028

Clear

Report Description of the APAC OTC Gastrointestinal Drugs Market Analysis

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for APAC OTC Gastrointestinal Drugs Market Analysis
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the APAC OTC Gastrointestinal Drugs  Market  Analysis
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy based consulting analysis

APAC OTC Gastrointestinal Drugs Market Analysis Executive Summary

Gastrointestinal (GI) diseases affects stomach, large intestine and rectum, small intestine, esophagus, liver, gallbladder, and pancreas. The symptoms of GI diseases are heartburn, indigestion, bloating, constipation, and many more. The diseases of gastrointestinal have become common in the people across world.  Gastrointestinal diseases are caused by various reasons such as acid reflux, heartburn, indigestion, nausea and vomiting, peptic ulcer disease, abdominal pain syndrome, biliary tract disorders, gallbladder disorders, and gallstone pancreatitis.

Market Size and Key Findings

The APAC OTC Gastrointestinal Drugs Market Analysis size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 6.1% during the forecast period.

Market Dynamics

Market Growth Drivers Analysis

Gastrointestinal diseases has gained a tremendous attention over the last few years. Owing to increasing prevalence of different gastrointestinal diseases and disorders, encouraged many companies for initiating the research in the development of innovative and advanced drugs. Increasing prevalence of GI diseases, rising geriatric population, and increasing investment in research & development drives the growth of the Asia-Pacific gastrointestinal drugs market. Additionally, changing lifestyle and increasing awareness about the availability of the treatment fuel the Asia-Pacific gastrointestinal drugs market growth.

Market Restraints

The presence of misbranded & spurious drugs, and unavailability of lifelong cure may hinder the Asia-Pacific gastrointestinal drugs market growth over the review period.

COVID-19 impact on “APAC OTC Gastrointestinal Drugs Market”

Most industries across the world have been negatively impacted over the last few months. This can be attributed to significant disruptions experienced by their respective manufacturing and supply-chain operations as a result of various precautionary lockdowns, as well as other restrictions that were enforced by governing authorities across the globe. The same applies to the global Gastrointestinal Drugs market.

Competitive Landscape

Key Players

Takeda pharmaceutical, Valeant Pharmaceuticals International, Inc., Janssen Biotech, Inc., Bayer AG, Sanofi, AstraZeneca, Allergan Plc, GlaxoSmithKline, Abbott Laboratories, Boehringer Ingelheim GmbH and Allergan Plc.

Products in Pipeline

  • In March 2016, Allergan enters into licensing agreement with AstraZeneca to obtain worldwide rights to MEDI2070 inflammatory disorder development program. Which will expands Allergan’s Innovative Gastroenterology Pipeline into Inflammatory Bowel Disease.

Notable Recent Deals

In June 2017, Abbott accepted shareholders amended merger from Alere. Merger will increase the revenue in Abbott’s pharmaceuticals segment.

In October 2016, Allergan has acquired GI Disease Subsidiary of Rhythm Holding Company, acquisition will expand the innovative gastroenterology segment of Allergen indirectly increasing revenue.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

The government of Asian countries have been educating the people about the various diseases and their treatment availability. Relief International, with funding from the European Union, is working with Bangladesh citizens to implement One Health Asia, a program designed to prevent zoonotic diseases through training and education. Many organizations and companies are conducting surveys and programs to educate the peoples about the diseases and treatment.

1. Report Description of the APAC OTC Gastrointestinal Drugs Market Analysis
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. APAC OTC Gastrointestinal Drugs Market Analysis Executive Summary
2.1 APAC OTC Gastrointestinal Drugs Market Analysis – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects and Key findings
3. Market Dynamics of APAC OTC Gastrointestinal Drugs Market Analysis
3.1 Market Growth Drivers Analysis
3.1.1 Increasing prevalence of Gastrointestinal diseases
3.1.2 Increasing investments and funding in the field of Life Science Research
3.1.3 Increasing awareness among the people
3.2 Market Restraints Analysis
3.2.1 Presence of misbranded and Spurious drugs
3.3 Covid-19 Market Impact Analysis
4. APAC OTC Gastrointestinal Drugs Market Segmentation
4.1 By Drug Class:
4.1.1 Acid Neutralizers
4.1.2 Laxatives And Antidiarrheal
4.1.3 Antiemetics
4.1.4 Antiulcer
4.2 By Route of Administration:
4.2.1 Oral
4.2.2 Parental
4.3 By Application:
4.3.1 Inflammatory Ulcerative Colitis
4.3.2 Crohn’s Disease
4.3.3 Irritable Bowel Syndrome
4.3.4 Gastroenteritis
4.3.5 Celiac Disease
4.3.6 Others
4.4 By Distribution Channel:
4.4.1 Hospital Pharmacies
4.4.2 Retail Pharmacies
4.4.3 Online Pharmacies
5. APAC OTC Gastrointestinal Drugs Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives OTC Gastrointestinal Drugs Market
6.4 Notable recent deals in OTC Gastrointestinal Drugs Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers & Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Pfizer Inc. Company overview
Product & Services, Strategies & Financials
7.2 Abbott Company overview
Product & Services, Strategies & Financials
7.3 Allergan Plc. Company overview
Product & Services, Strategies & Financials
7.4 AstraZeneca Company overview
Product & Services, Strategies & Financials
7.5 GlaxoSmithKline plc. Company overview
Product & Services, Strategies & Financials
7.6 Eli Lilly Company overview
Product & Services, Strategies & Financials
7.7 F. Hoffmann-La Roche Ltd company overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development of OTC Gastrointestinal Drugs market
9.2 Future Opportunities
10. Strategic Recommendations

APAC OTC Gastrointestinal Drugs Market Analysis Segmentation

By Drug Class:

On the basis of drug class, Asia-Pacific gastrointestinal drugs market is segmented into acid neutralizers, laxatives & antidiarrheal, antiemetics, antiulcer, and others. Acid neutralizers segment accounted for the largest market share with 33.3% of the Asia-Pacific gastrointestinal drug market, by drug types in 2019.

By Route of Administration:

In terms of route of administration, oral segment accounted for the largest share of the Asia Pacific gastrointestinal drugs market in 2019.

By Application:

In terms of application, the inflammatory ulcerative colitis segment accounted for the largest share of the Asia Pacific gastrointestinal drugs market in 2019.

By Distribution Channel:

In terms of distribution channel, the retail pharmacies segment accounted for the largest share of the Asia Pacific gastrointestinal drugs market in 2019.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements